Polen Capital Management’s UroGen Pharma URGN Stock Holding History

Polen Capital Management’s Portfolio URGN Stock Details URGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Buy	+29,615	New	+$803K	0.01%	160

Other funds holding URGN

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Polen Capital Management's URGN Position: Q2 2026 in Review

Polen Capital Management opened a new position in UroGen Pharma (URGN) in Q2 2026: 29,615 shares worth $1.09M. The stake represents 0.01% of the portfolio and ranks #160 among its holdings.

30 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

Polen Capital Management held 29,615 shares of UroGen Pharma worth $1.09M as of Q2 2026.
UroGen Pharma was a new Polen Capital Management position in Q2 2026.
UroGen Pharma made up 0.01% of Polen Capital Management's portfolio in Q2 2026, its #160 holding.
30 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on Polen Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.